During the past decade, Institut du Glaucome de Montréal conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institut du Glaucome de Montréal" are "Glaucoma" (2 trials) and "Glaucoma, Open Angle" (2 trials). Many other conditions were trialed in "Institut du Glaucome de Montréal" in a lesser frequency.

Most popular intervention types in "Institut du Glaucome de Montréal" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ahmed FP7 Glaucoma Valve" (1 trials), "Argon Laser Trabeculoplasty (ALT)" (1 trials), "SOLX Gold Shunt GMS-plus" (1 trials) and "SOLX Titanium Sapphire Laser (TiSaLT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut du Glaucome de Montréal" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institut du Glaucome de Montréal". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institut du Glaucome de Montréal, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut du Glaucome de Montréal, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".